Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Allogeneic Mesenchymal Stromal Cells for Angiogenesis and Neovascularization in No-option Ischemic Limbs; A Double-blind, Randomized, Placebo-controlled Trial

NCT03042572 is registered in ClinicalTrials.gov with Martin Teraa, MD, PhD as lead sponsor.

NCT NCT03042572
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03042572 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Allogeneic Mesenchymal Stromal Cells for Angiogenesis and Neovascularization in No-option Ischemic Limbs; A Double-blind, Randomized, Placebo-controlled Trial
Lead sponsor
Martin Teraa, MD, PhD
Phase
Phase 2/3
Overall status
Unknown status
Start date
December 31, 2018
Completion date
July 31, 2021
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases, peripheral arterial disease, vascular diseases